MENU
+Compare
EDGE
ETF ticker: BATS
AS OF
Jul 2 closing price
Price
$39.90
Change
+$0.07 (+0.18%)

EDGE MRBL Enhanced Equity ETF Forecast, Technical & Fundamental Analysis

The investment seeks capital appreciation... Show more

Category: #Trading
EDGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EDGE with price predictions
Jul 02, 2025

EDGE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for EDGE turned positive on June 27, 2025. Looking at past instances where EDGE's MACD turned positive, the stock continued to rise in of 2 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 06, 2025. You may want to consider a long position or call options on EDGE as a result. In of 5 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 13 cases where EDGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

EDGE broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

View a ticker or compare two or three
EDGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of linical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Category Trading

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR0.430.01
+1.38%
Heartcore Enterprises
QNST16.34N/A
N/A
QuinStreet
NJR45.05-0.19
-0.42%
New Jersey Resources Corp
FAST42.67-0.19
-0.44%
Fastenal Co
OPRX13.12-0.47
-3.46%
OptimizeRx Corp